[1] |
VAN DEN BEUKEN-VAN EVERDINGEN MH, HOCHSTENBACH LM, JOOSTEN EA, et al.Update on prevalence of pain in patients with cancer:systematic review and meta-analysis[J].J Pain Symptom Manage, 2016, 51(6):1070. doi: 10.1016/j.jpainsymman.2015.12.340 |
[2] |
LEE KH, KANG JH, OH HS, et al.Intravenous oxycodone versus intravenous morphine in cancer pain:a randomized, open-label, parallel-group, active-control study[J].Pain Res Manag, 2017, 2017(37):1. |
[3] |
谢林浩, 刘驯炎.不同剂量盐酸羟考酮缓释片治疗胃癌重度癌痛的前瞻性对照研究[J].2017, 30(8): 1050. |
[4] |
彭秀兰, 郭荣春, 姚文秀, 等.盐酸羟考酮缓释片治疗中重度癌痛的疗效及经济学分析[J].西部医学, 2015, 27(10):1538. doi: 10.3969/j.issn.1672-3511.2015.10.029 |
[5] |
卜岗, 孙欣, 王辉, 等.盐酸羟考酮缓释片联合氟哌噻吨美利曲辛片治疗晚期癌痛的疗效观察[J].现代肿瘤医学, 2018(4):609. doi: 10.3969/j.issn.1672-4992.2018.04.032 |
[6] |
李应宏, 张宇杰, 刘生永, 等.硫酸吗啡缓释片联合锝[99Tc]亚甲基二膦酸盐治疗骨转移癌痛疗效观察[J].内科, 2017, 12(4):465. |
[7] |
CHEN DL, LI YH, WANG ZJ, et al.The research on long-term clinical effects and patients' satisfaction of gabapentin combined with oxycontin in treatment of severe cancer pain[J].Medicine, 2016, 95(42):e5144. |
[8] |
SANTIS SD, BORGHESI C, RICCIARDI S, et al.Analgesic effectiveness and tolerability of oral oxycodone/naloxone and pregabalin in patients with lung cancer and neuropathic pain:an observational analysis[J].Onco Targets Therapy, 2016, 9:4043. doi: 10.2147/OTT |
[9] |
易军.放疗联合盐酸羟考酮缓释片治疗骨转移癌痛的效果观察[J].中国当代医药, 2015, 22(29):70. |
[10] |
FRAGNI M, BONINI SA, STABILE A, et al.Inhibition of survivin is associated with zoledronic acid-induced apoptosis of prostate cancer cells[J].Anticancer Res, 2016, 36(3):913. |